Merck News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

08.07.20	Foghorn Therapeutics, Merck Enter Strategic Collaboration - Quick Facts (RTTNews)
08.07.20	AstraZeneca: Lynparza Gets EU Approval For BRCA-mutated Metastatic Pancreatic Cancer (RTTNews)
06.07.20	Merck: New Analyses Show Additional Efficacy Data For Islatravir, Doravirine Combination (RTTNews)
06.07.20	Ascentage, Merck To Evaluate APG-115 In Combination With KEYTRUDA In Advanced Solid Tumors (RTTNews)
30.06.20	FDA OKs Merck's Keytruda As First-line Treatment For Metastatic Colorectal Cancer (RTTNews)
29.06.20	Novo Nordisk Announces Approval Of Rybelsus In Japan For Treatment Of Type 2 Diabetes (RTTNews)
22.06.20	Merck: KEYTRUDA Approved For New Indication In China - Quick Facts (RTTNews)
17.06.20	Merck: FDA Approves Second Biomarker-Based Indication For KEYTRUDA (RTTNews)
17.06.20	Merck Prices $4.5 Bln Public Debt Offering Of Senior Unsecured Notes - Quick Facts (RTTNews)
05.06.20	CYCN Awaits Sickle Cell Disease Data, TTPH Finalizes Its Suitor, ADMS Faces FDA In Feb (RTTNews)
04.06.20	List Of 'Operation Warp Speed' Finalists, SAVA To Reassess AD Study Results; KZR Jumps On MISSION (RTTNews)
30.05.20	The Week That Was: MRK Enters COVID Space, GSK's 1Bln Dose Target, Roche, GILD Team Up For REMDACTA (RTTNews)
28.05.20	Merck and Twitch Join Forces on World Multiple Sclerosis Day to Connect People Living With MS (PR Newswire)
27.05.20	ARGX Soars On ADAPT Trial Data, MRK's Deals & Collaborations To Fight COVID-19, ALNY ON Watch (RTTNews)
26.05.20	Merck Inks Deals, Joins Coronavirus Vaccine Race (RTTNews)
26.05.20	Merck, Ridgeback Bio Collaborate To Develop Novel Antiviral Candidate EIDD-2801 (RTTNews)
26.05.20	Merck To Buy Privately-held Themis - Quick Facts (RTTNews)
26.05.20	Biotech Stocks Facing FDA Decision In June 2020 (RTTNews)
20.05.20	AstraZeneca: Lynparza Approved In US For HRR Gene-mutated Prostate Cancer (RTTNews)
14.05.20	/C O R R E C T I O N -- EMD Serono/ (PR Newswire)
14.05.20	Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020 (PR Newswire)
14.05.20	Breakthrough Innovation in Cancer Care From EMD Serono Pipeline to Be Presented at ASCO 2020 (PR Newswire)
11.05.20	AstraZeneca: FDA Approves Lynparza In Treatment Of HRD-positive Ovarian Cancer (RTTNews)
30.04.20	Data From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care (PR Newswire)
28.04.20	Merck Q1 Results Top Estimates; But Cuts 2020 Outlook (RTTNews)
28.04.20	Merck & Co Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
28.04.20	Biotech Stocks Facing FDA Decision In May 2020 (RTTNews)
24.04.20	AZN : Lynparza Shows Overall Survival Benefit In Late-stage Trial On MCRPC (RTTNews)
14.04.20	Stock Alert: Will Uptrend At Merck & Co. Continue? (RTTNews)
13.04.20	AstraZeneca & Merck Announce FDA Approval Of KOSELUGO - Quick Facts (RTTNews)
08.04.20	KPTI To Test XPOVIO In COVID-19, PTCT Will Have To Wait, SAGE Slashes Workforce (RTTNews)
06.02.20	BTAI Hits A High, TNXP's RECOVERY Fails, MRK Plans A Spin-off (RTTNews)
05.02.20	Merck Q4 Profit Tops; Plans Spin-off Of Women's Health, Biosimilar Businesses (RTTNews)
05.02.20	Merck & Co Inc. Q4 adjusted earnings Beat Estimates (RTTNews)
28.01.20	Biotech Stocks Facing FDA Decision In February 2020 (RTTNews)
28.01.20	XLRN Soars, FDA Approves Triple Combo Pill For Type 2 Diabetes, MGEN On Watch (RTTNews)
23.01.20	Merck : Canada Oks KEYTRUDA As First-Line Treatment For Advanced RCC (RTTNews)
20.01.20	AstraZeneca: FDA's ODD For Imfinzi, Tremelimumab; Priority Review For Lynparza (RTTNews)
14.01.20	Just - Evotec Grants MSD Access To J.POD(R) Facility - Quick Facts (RTTNews)
13.01.20	AZN : Lynparza-bevacizumab Granted Priority Review In US For Ovarian Cancer (RTTNews)
09.01.20	FDA Nod For MRK, All Eyes On AGTC, ACTION Boosts APLT (RTTNews)
07.01.20	LIFE Gets A Boost With Kyorin Deal, XERS Up 20% After-Hrs, ITCI On Watch (RTTNews)
31.12.19	Biotech Stocks Facing FDA Decision In January 2020 (RTTNews)
31.12.19	ARDS Turning Heads, AXSM's Momentum Continues, SVRA Abuzz, Jiankui Jailed (RTTNews)
30.12.19	AstraZeneca: Lynparza Approved In US For Pancreatic Cancer - Quick Facts (RTTNews)
20.12.19	FDA Approves Ervebo Vaccine For Prevention Of Ebola Virus Disease (RTTNews)
20.12.19	FDA Grants Approval For Merck's Ebola Vaccine Ervebo - Quick Facts (RTTNews)
18.12.19	AstraZeneca Says FDA Panel Backs Lynparza Use For Pancreatic Cancer (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

22:34		Dow Jones-Handel aktuell: Dow Jones verbucht letztendlich Verluste
20:03		Schwache Performance in New York: Dow Jones gibt nachmittags nach
18:01		Gewinne in New York: Dow Jones verbucht am Mittwochmittag Zuschläge
17:58		Börse London: FTSE 100 zum Ende des Mittwochshandels mit positivem Vorzeichen
17:58		Starker Wochentag in Europa: STOXX 50 klettert zum Handelsende

22:34

Dow Jones-Handel aktuell: Dow Jones verbucht letztendlich Verluste

20:03

Schwache Performance in New York: Dow Jones gibt nachmittags nach

18:01

Gewinne in New York: Dow Jones verbucht am Mittwochmittag Zuschläge

17:58

Börse London: FTSE 100 zum Ende des Mittwochshandels mit positivem Vorzeichen

17:58

Starker Wochentag in Europa: STOXX 50 klettert zum Handelsende

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V

Nachrichten zu Merck Co.

Aktien Top/Flop

Merck Peer Group Nachrichten

Meistgelesene Nachrichten